Genmab — April 2011
-
nej 82,1
-
7-9 kvartal.....
-
det er q311
-
jeg synes det kører som på skinner fra DSB
-
men altså lad os alligevel holde fast i at vi gået 8% op QoQ og 100Q YoY
-
Newcap ændrer sit formål......http://www.proinvestor.com/aktienyt/547626/Selskabsmeddelelse-nr.-6--2011
-
Og Michael Vinther, Advokat fra Accura ind i bestyrelsen
-
wrong chat sorry
-
men altså jeg forstår dig godt. men sådan noget markedspentration er svært og få 3rd line synes jeg egentligt det fortsat er godkendt
-
men vi mangler jo så hele udrulningen af de andre indikationer, så selv hvis at vi har nået toppen af omsætning for arzerra i refrac
-
hvilket jeg ikke tro, så er der fortsat alle de andre indikationer
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind